Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Reich

Showing results (141-150 of 164) with videos related to

Pageof 17
Sort By:
Cancer|December 15, 1983
Initial clinical trials of the subrenal capsule assay as a predictor of tumor response to chemotherapyT W Griffin, A E Bogden, S D Reich, et al.
British Journal of Clinical Pharmacology|July 22, 2014
A randomized phase 1 pharmacokinetic trial comparing the potential biosimilar PF-05280014 with trastuzumab in healthy volunteers (REFLECTIONS B327-01)Donghua Yin, Kerry B Barker, Ruifeng Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2005
Phase I trial of the oral antiangiogenesis agent AG-013736 in patients with advanced solid tumors: pharmacokinetic and clinical resultsHope S Rugo, Roy S Herbst, Glenn Liu, et al.
Investigational New Drugs|January 1, 1986
Recombinant gamma interferon in advanced breast cancer: a phase II trialH B Muss, M Caponera, P J Zekan, et al.
British Journal of Haematology|October 28, 2017
A phase 1 clinical trial evaluating marizomib, pomalidomide and low-dose dexamethasone in relapsed and refractory multiple myeloma (NPI-0052-107): final study resultsAndrew Spencer, Simon Harrison, Jeffrey Zonder, et al.
Neurology|November 19, 2008
Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosisPablo Villoslada, Jorge Sepulcre, Jon Toledo, et al.
Urologic Oncology|August 6, 2011
A non-comparative randomized phase II study of 2 doses of ATN-224, a copper/zinc superoxide dismutase inhibitor, in patients with biochemically recurrent hormone-naïve prostate cancerJianqing Lin, Marianna Zahurak, Tomasz M Beer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2001
Multi-institutional phase I/II trial of oral bexarotene in combination with cisplatin and vinorelbine in previously untreated patients with advanced non-small-cell lung cancerF R Khuri, J R Rigas, R A Figlin, et al.
Molecular Psychiatry|March 7, 2012
Managing sensitive phenotypic data and biomaterial in large-scale collaborative psychiatric genetic research projects: practical considerationsS Y Demiroglu, D Skrowny, M Quade, et al.
Sexual Development : Genetics, Molecular Biology, Evolution, Endocrinology, Embryology, and Pathology of Sex Determination and Differentiation|April 9, 2008
Small supernumerary marker chromosomes (sSMC) in patients with a 45,X/46,X,+mar karyotype - 17 new cases and a review of the literatureT Liehr, K Mrasek, S Hinreiner, et al.
Pageof 17

Showing results (141-150 of 164) with videos related to

Sort By:
Pageof 17
Cancer|December 15, 1983
Initial clinical trials of the subrenal capsule assay as a predictor of tumor response to chemotherapyT W Griffin, A E Bogden, S D Reich, et al.
British Journal of Clinical Pharmacology|July 22, 2014
A randomized phase 1 pharmacokinetic trial comparing the potential biosimilar PF-05280014 with trastuzumab in healthy volunteers (REFLECTIONS B327-01)Donghua Yin, Kerry B Barker, Ruifeng Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2005
Phase I trial of the oral antiangiogenesis agent AG-013736 in patients with advanced solid tumors: pharmacokinetic and clinical resultsHope S Rugo, Roy S Herbst, Glenn Liu, et al.
Investigational New Drugs|January 1, 1986
Recombinant gamma interferon in advanced breast cancer: a phase II trialH B Muss, M Caponera, P J Zekan, et al.
British Journal of Haematology|October 28, 2017
A phase 1 clinical trial evaluating marizomib, pomalidomide and low-dose dexamethasone in relapsed and refractory multiple myeloma (NPI-0052-107): final study resultsAndrew Spencer, Simon Harrison, Jeffrey Zonder, et al.
Neurology|November 19, 2008
Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosisPablo Villoslada, Jorge Sepulcre, Jon Toledo, et al.
Urologic Oncology|August 6, 2011
A non-comparative randomized phase II study of 2 doses of ATN-224, a copper/zinc superoxide dismutase inhibitor, in patients with biochemically recurrent hormone-naïve prostate cancerJianqing Lin, Marianna Zahurak, Tomasz M Beer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2001
Multi-institutional phase I/II trial of oral bexarotene in combination with cisplatin and vinorelbine in previously untreated patients with advanced non-small-cell lung cancerF R Khuri, J R Rigas, R A Figlin, et al.
Molecular Psychiatry|March 7, 2012
Managing sensitive phenotypic data and biomaterial in large-scale collaborative psychiatric genetic research projects: practical considerationsS Y Demiroglu, D Skrowny, M Quade, et al.
Sexual Development : Genetics, Molecular Biology, Evolution, Endocrinology, Embryology, and Pathology of Sex Determination and Differentiation|April 9, 2008
Small supernumerary marker chromosomes (sSMC) in patients with a 45,X/46,X,+mar karyotype - 17 new cases and a review of the literatureT Liehr, K Mrasek, S Hinreiner, et al.
Pageof 17